Brevan Howard Capital Management LP Ultragenyx Pharmaceutical Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 35,201 shares of RARE stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,201
Previous 16,241
116.74%
Holding current value
$1.26 Million
Previous $902,000
64.08%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
346Shares Held
84.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$200 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$153 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$97.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$89.7 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.5B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...